| Literature DB >> 24031234 |
Rita de Cássia Figueira Silva1, Elmiro Rosendo do Nascimento, Virgínia Léo de Almeida Pereira, Maria Lúcia Barreto, Maria da Graça Fichel do Nascimento.
Abstract
Newcastle disease is characterized by respiratory manifestations in association with nervous and/or digestive symptoms. Its prevention is done by vaccination with live attenuated (lentogenic strains) and/or killed vaccines. The lentogenic strains can lead to strong post-vaccination reaction, principally due to the presence of other pathogenic agents. Among them, Mycoplasma synoviae is worldwide important, mainly in Brazil. The dissemination of this agent in poultry flocks has been achieved due to difficulties in diagnosis and disease reproduction, virulence variations among different M.synoviae strains, and attribution of typical M.synoviae disease manifestation to other disease agents. This experimental study in SPF chicks (Gallus gallus), previously infected by M.synoviae and thereafter vaccinated against Newcastle disease, was done with the objective of evaluating M.synoviae pathogenicity through assessment of post-vaccinal respiratory reactions and serologic responses to Newcastle disease virus vaccine in the absence of environmental factors. A total of 86 three days old chicks were used, being 57 infected by eye and nostril drop, with chicken activated M. synoviae strain WVU 1853. Seven days later, 21 mycoplasma infected birds plus 29 not mycoplasma infected ones were vaccinated against Newcastle disease. As results, the not infected and vaccinated birds yielded, significantly, higher and longer lasting serologic responses to Newcastle disease vaccine virus than those infected and vaccinated. Similarly, the infected and vaccinated birds yielded lower serologic reactions to M.synoviae than those only mycoplasma infected. No post-vaccinal respiratory reaction was observed in the vaccinated birds.Entities:
Keywords: Mycoplasma; Newcastle disease; serology; vaccine
Year: 2008 PMID: 24031234 PMCID: PMC3768380 DOI: 10.1590/S1517-838220080002000033
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Experimental Design and procedures.
| Ages (days) | Procedures | Experimental Groups | Sampling | Diagnostic Approach |
|---|---|---|---|---|
| 1 | bleeding | Nd | serum | serology MS/MG and NDV |
| 3 | MS infection | Nd | Nd | - |
| 10 | bleeding | Nd | serum lung trachea Nd Nd | serology MS/MG and MS molecular detection (PCR) (7 dpi) |
| Groups establishment | MSI; MSI-NDVC; NDVC | Nd | - | |
| ND vaccination | MSI-NDVC; NDVC | Nd | - | |
| 17 | bleeding necropsy | MSI; MSI-NDVC; NDVC MSI; MSI-NDVC | serum lung trachea | serology MS/MG (14 dpi) and NDV (7 dpv) MS molecular detection (PCR) (14 dpi) |
| 24 | bleeding necropsy | MSI; MSI-NDVC; NDVC MSI; MSI-NDVC | serum lung trachea | serology MS/MG (21 dpi) and NDV (14 dpv) MS molecular detection (PCR) (21 dpi) |
| 31 | bleeding necropsy | MSI; MSI-NDVC; NDVC MSI; MSI-NDVC | serum lung trachea | serology MS/MG (28 dpi) and NDV (21 dpv) MS molecular detection (PCR) (28 dpi) |
| 38 | bleeding necropsy | MSI; MSI-NDVC; NDVC MSI; MSI-NDVC | serum lung trachea | serology MS/MG (35 dpi) and NDV (28 dpv) MS molecular detection (PCR) (35 dpi) |
| 45 | bleeding necropsy | MSI; MSI-NDVC; NDVC MSI; MSI-NDVC | serum lung trachea | serology MS/MG (42dpi) and NDV (35 dpv) MS molecular detection (PCR) (42 dpi) |
Percentages of M. synoviae (MS) seropositivity by SPA in undiluted (UD) and diluted (D) sera and GMT/HI (log2) to Newcastle Disease (ND) vaccine virus in MS infected (MSI), MS infected and ND vaccinated (MSI-NDVC) and not MS infected, but ND vaccinated (NDVC) birds groups.
| Days of age | dpi | dpv | Experimental Groups | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MSI | MSI-NDVC | NDVC | |||||||||
| 50.0 a | 20.0 a | 0 | Nd | Nd | Nd | Nd | Nd | Nd | |||
| 90.0a | 60.0 a | 0 | 66.7 b | 22.3 b | 0 | 0 | Nd | 0 | |||
| 55.6 a | 56.6 a | 0 | 22.3 b | 11.2 b | 4.5a | 0 | Nd | 5.0 b | |||
| 50.0 a | 50.0 a | 0 | 20.0 b | 10.0 b | 3.2 a | 0 | Nd | 5.0 b | |||
| 37.5 a | 25.0 a | 0 | 22.3 b | 0 b | 0 a | 0 | Nd | 4.8 b | |||
| 20.0 a | 0 a | 0 | 16.7 b | 0 b | 0 a | 0 | Nd | 3.2 b | |||
SPA (%) – row numbers followed by different letters, differ significantly (p<0.05) by chi-square test;
HI (GMT) – row numbers followed by different letters, differ significantly (p<0.05) by Student’s t-test.